Related Experiment Video
Updated: May 17, 2025

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Published on: September 27, 2024
Outpatient-based buprenorphine-assisted opioid withdrawal management: A preliminary prospective observational study
Avinash Jhajharia1, Priyanka Saha1, Piyali Mandal1
1National Drug Dependence Treatment Centre, AIIMS, New Delhi, India.
Background:
Indian guidelines mention the use of buprenorphine in opioid withdrawal in both outpatient and inpatient setting.
Aim:
This is the first study aiming at assessing the feasibility aspects of outpatient-based buprenorphine-assisted opioid withdrawal treatment for opioid dependence.
Methods:
In this prospective observational study, 30 men with opioid dependence, planned for outpatient-based withdrawal management, were recruited by purposive sampling and were assessed at baseline, 2, 4, and 12 weeks using validated tools. Abstinence was validated by a urine toxicology screen.
Results:
The median age of the sample was 24 (21.75-28.0) years. About 67% retained in treatment with a treatment perception score of 4.1 (4.0-4.4) and a significant reduction of craving and withdrawal scores. More than 80% were abstinent at 12 weeks.
Conclusion:
The study findings suggest that outpatient-based buprenorphine-assisted acute opioid withdrawal management is a feasible and acceptable treatment. Considering the relatively few inpatient addiction treatment settings, the findings are promising.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Dependence
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Opioid Receptors: Overview

